| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC67147 | N-Methyl-p-tyramine Hydrochloride Featured | N-Methyltyramine (hydrochloride) can be isolated from the plants of the Citrus genus. |
|
| DC67148 | 4-Nitro-3-(trifluoromethyl)aniline Featured | 4-Nitro-3-(trifluoromethyl)aniline is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|
| DC67149 | DL-N-Isopropyloctopamine Featured |
|
|
| DC67150 | (2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid Featured |
|
|
| DC67151 | 2-Chloro-4-fluoro-3-methylbenzonitrile Featured |
|
|
| DC67152 | Octopamine Featured | Octopamine is an alpha-adrenergic sympathomimetic amine biosynthesized from tyramine. Octopamine may be found in the CNS, platelets, and in invertebrate nervous systems. It is used to treat hypotension and may acy as a cardiotonic. |
|
| DC67153 | 5-nitrothiophene-2-carbaldehyde Featured |
|
|
| DC67154 | OTE-AC Featured |
|
|
| DC67155 | 3-(dibenzo[b,d]furan-4-yl)phenyl)boronic acid Featured |
|
|
| DC67156 | tert-Butyl 3-formylpyrrolidine-1-carboxylate Featured | tert-Butyl 3-formylpyrrolidine-1-carboxylate is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|
| DC67157 | Dibenzo[b,d]furan-1-ylboronicacid Featured |
|
|
| DC67158 | ANTHRACENE, 9-[1,1'-BIPHENYL]-2-YL- Featured |
|
|
| DC67159 | Thioxanthen-9-one Featured |
|
|
| DC67160 | 1-Bromodibenzofuran Featured |
|
|
| DC60703 | 164A10 Featured | 164A10 is a potent and effective Pin1 degrader with IC50 of 4.1 nM in DELFIA displacement assay with significantly improved properties over the parent molecule BJP-07-017-3. |
|
| DC60704 | 158H9 Featured | 158H9 is a potent and effective Pin1 degrader with IC50 of 21.4 nM in DELFIA displacement assay with significantly improved properties over the parent molecule BJP-07-017-3. |
|
| DC60705 | Lipid FO-32 Featured | FO-32 is an artificial intelligence-guided designed ionizable lipid for RNA delivery to the muscle, lung and nose. FO-32 LNPs enable potent transfection throughout the whole ferret lung epithelium, from trachea to alveoli. |
|
| A758 | Ibritumomab Featured |
|
|
| A759 | Regeneron patent anti-CD20 Featured |
|
|
| A760 | Samalizumab Featured | Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research. |
|
| A761 | FR104 Featured |
|
|
| A762 | Lulizumab Featured | Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling. |
|
| A763 | Galiximab Featured | Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen and blocks CD80–CD28 binding. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma. |
|
| A764 | Visilizumab Featured | Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research. |
|
| A765 | Otelixizumab Featured | Otelixizumab (ChAglyCD3) is an anti-human CD3 monoclonal antibody and can be used for the research of type 1 diabetes. |
|
| A766 | ITRI patent anti-CD34 Featured |
|
|
| A767 | Ona Thera Patent Anti-Cd36 Featured |
|
|
| DC60706 | Lipid FO-35 Featured | FO-35 is an artificial intelligence-guided designed ionizable lipid for RNA delivery to the muscle, lung and nose. FO-35 LNPs enable potent transfection throughout the whole ferret lung epithelium, from trachea to alveoli. |
|
| A768 | Isatuximab Featured | Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions. |
|
| A769 | Felzartamab Featured | Felzartamab (MOR-202) is a human monoclonal antibody that targets CD38 and can be used in multiple myeloma research. |
|
